ADAP
Adaptimmune Therapeutics
ADAP
ADAP
68 hedge funds and large institutions have $299M invested in Adaptimmune Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 19 closing their positions.
Holders
68
Holders Change
-12
Holders Change %
-15%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
7
Increased
22
Reduced
16
Closed
19
Calls
$6K
Puts
$41K
Net Calls
-$35K
Net Calls Change
-$2.15M